Literature DB >> 15738471

NNT for studies with long-term follow-up.

Mario L de Lemos.   

Abstract

Mesh：

Year:  2005        PMID： 15738471      PMCID： PMC550612          DOI： 10.1503/cmaj.1041426

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

Review 1.  Calculating the number needed to treat for trials where the outcome is time to an event.

Authors:  D G Altman; P K Andersen
Journal:  BMJ       Date:  1999-12-04

2.  How to survive the survival plots.

Authors:  Mário L de Lemos
Journal:  Lancet       Date:  2002-09-21       Impact factor: 79.321

Review 3.  Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat.

Authors:  Alexandra Barratt; Peter C Wyer; Rose Hatala; Thomas McGinn; Antonio L Dans; Sheri Keitz; Virginia Moyer; Gordon Guyatt For
Journal:  CMAJ       Date:  2004-08-17       Impact factor: 8.262
  3 in total
  8 in total

1.  The "number needed to treat" turns 20--and continues to be used and misused.

Authors:  Finlay A McAlister
Journal:  CMAJ       Date:  2008-09-09       Impact factor: 8.262

2.  Prostate cancer risk in pre-diabetic men: a matched cohort study.

Authors:  Adedayo A Onitilo; Richard L Berg; Jessica M Engel; Rachel V Stankowski; Ingrid Glurich; Gail M Williams; Suhail A R Doi
Journal:  Clin Med Res       Date:  2013-05-08

3.  Statins and hip fracture prevention--a population based cohort study in women.

Authors:  Arja Helin-Salmivaara; Maarit J Korhonen; Petri Lehenkari; Seppo Y T Junnila; Pertti J Neuvonen; Päivi Ruokoniemi; Risto Huupponen
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

4.  Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients.

Authors:  Jan Zirk-Sadowski; Jane A Masoli; W David Strain; Joao Delgado; William Henley; Willy Hamilton; David Melzer; Alessandro Ble
Journal:  Am J Gastroenterol       Date:  2017-03       Impact factor: 10.864

5.  Prone Positioning in Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19: A Cohort Study and Analysis of Physiology.

Authors:  Mehdi C Shelhamer; Paul D Wesson; Ian L Solari; Deanna L Jensen; William Alex Steele; Vihren G Dimitrov; John Daniel Kelly; Shazia Aziz; Victor Perez Gutierrez; Eric Vittinghoff; Kevin K Chung; Vidya P Menon; Herman A Ambris; Sanjiv M Baxi
Journal:  J Intensive Care Med       Date:  2021-02       Impact factor: 3.510

Review 6.  Calculation of NNTs in RCTs with time-to-event outcomes: a literature review.

Authors:  Mandy Hildebrandt; Elke Vervölgyi; Ralf Bender
Journal:  BMC Med Res Methodol       Date:  2009-03-20       Impact factor: 4.615

7.  Prone Positioning in Moderate to Severe Acute Respiratory Distress Syndrome due to COVID-19: A Cohort Study and Analysis of Physiology.

Authors:  Mehdi Shelhamer; Paul D Wesson; Ian L Solari; Deanna L Jensen; William Alex Steele; Vihren G Dimitrov; John Daniel Kelly; Shazia Aziz; Victor Perez Gutierrez; Eric Vittinghoff; Kevin K Chung; Vidya P Menon; Herman A Ambris; Sanjiv M Baxi
Journal:  Res Sq       Date:  2020-08-17

8.  Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South-East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial.

Authors:  Takashi Wada; Kazumi Mori-Anai; Yutaka Kawaguchi; Hideyuki Katsumata; Hidetaka Tsuda; Mitsutaka Iida; Kenji Arakawa; Meg J Jardine
Journal:  J Diabetes Investig       Date:  2021-08-03       Impact factor: 4.232
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.